Build your own keyword analysis with our tools
SEO Report
Server Infos

HTML Analysis

Page Status


Highlighted Content

Anacor - Developing Small-Molecule Therapeutics Derived From Our Boron Chemisty Platform


The Investor Relations section contains Anacor's quarterly corporate performance reports, financial reports, press and event informaytion, and stockholder information.


Anacor Pharaceuticals Investors


May 8-11, 2013 - Edinburgh, Scotland
April 25, 2013 - Emeryville, CA
October 14-18, 2012 - Dallas, TX
August 16-19, 2012 - Washington, DC
August 15-19, 2012 - Boston, MA
May 20-23, 2012 - Tucson, AZ
May 9-12, 2012 - Raleigh, NC





Text Analysis

Cloud of Keywords from all content
High relevance


Medium relevance

meeting pharmaceuticals american dermatology

Low relevance

american dermatology reserved academy national rights july annual august platform boron chemistry investigative

Very Low relevance
reserved academy national rights july annual august platform boron chemistry investigative dallas malaria emeryville april october 14-18 8-11 conference wednesday healthcare securities jmp june secures edinburgh scotland facility loan $45 international regional symposium 9-12 medicinal 33rd tucson raleigh society policy terms privacy contact sitemap 20-23 summer 16-19 washington issx onychomycosis tuesday north 100th podiatric 15-19 boston scientific association medical 18th data overview sec filings press anacor stockholder resume working opportunities send releases events presentations corporate request email alerts overview press coverage information faq analyst governance stockholder values job trials overview mission derived chemisty therapeutics small-molecule developing overview management board directors strategic health neglected diseases clinical 052 animal us overview tavaborole an2718 an2728 an2898 gsk alliances partnering contact releases publications scientific presentations contact opportunities view market attractive address pipeline thursday topical treatment tavaborole phase pivotal candidates product opencube exploiting copyright menus infinite advantages discovered proprietary boron-based development clinical advanced toenail

Highlighted Content Analysis

Cloud of Keywords from all content
High relevance


Medium relevance

Low relevance

reports 2013 anacor august

Very Low relevance
reports 2013 anacor august emeryville october 14-18 april scotland anacor pharaceuticals investors raleigh 9-12 tucson 15-19 boston washington 16-19 dallas edinburgh 20-23 8-11 boron chemisty platform derived therapeutics developing small-molecule investor relations press event informaytion financial performance quarterly corporate stockholder